Rochester General Hospital

Form 483 issued February 9, 2015 · Rochester, New York

Inspection
Feb 7 – Feb 9, 2015
Observations
1
Pages
2
FEI number
1371719

In short: On February 9, 2015, FDA issued a Form 483 with 1 observation to Rochester General Hospital in Rochester, New York (FEI 1371719) after an inspection that ran Feb 7 – Feb 9, 2015. The investigator was Nicholas C. Mendiola. Most observations concern cAPA; the most-cited regulation is 21 CFR 803.17 (what are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 803.17 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written MDR procedures have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Rochester General Hospital?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 803.17 (what are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?). The opening words of each observation are shown on this page.

Who inspected Rochester General Hospital?

Nicholas C. Mendiola is named on this Form 483, for the inspection of Feb 7 – Feb 9, 2015. Each investigator has a profile showing what they cite most.

When was Rochester General Hospital inspected by FDA?

The inspection ran Feb 7 – Feb 9, 2015, and the Form 483 is dated February 9, 2015.

How do I get the full Form 483 for Rochester General Hospital?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free